Zobrazeno 1 - 10
of 102
pro vyhledávání: '"Toshinari Suzuki"'
Autor:
Chisa Inoue, Kota Nishihama, Aoi Hayasaki, Yuko Okano, Akinobu Hayashi, Kazuhito Eguchi, Mei Uemura, Toshinari Suzuki, Taro Yasuma, Takeshi Inoue, Tohru Yorifuji, Shugo Mizuno, Esteban C. Gabazza, Yutaka Yano
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
The patient is a 28-year-old Japanese man diagnosed with severe congenital hyperinsulinemic-hypoglycemia six months after birth. Clinical records revealed no imaging evidence of pancreatic tumor at the time of diagnosis. Subsequently, he had developm
Externí odkaz:
https://doaj.org/article/c788ac1bd7904ce388c0a6e8944a03f2
Autor:
Mei Uemura, Yutaka Yano, Toshinari Suzuki, Taro Yasuma, Toshiyuki Sato, Aya Morimoto, Samiko Hosoya, Chihiro Suminaka, Hiromu Nakajima, Esteban C. Gabazza, Yoshiyuki Takei
Publikováno v:
Diabetes & Metabolism Journal, Vol 41, Iss 4, Pp 265-274 (2017)
BackgroundContinuous glucose monitoring (CGM) is reported to be a useful technique, but difficult or inconvenient for some patients and institutions. We are developing a glucose area under the curve (AUC) monitoring system without blood sampling usin
Externí odkaz:
https://doaj.org/article/dc742b89c3284130893a55ac1be9667c
Autor:
Kota Nishihama, Chisa Inoue, Kohei Nishikawa, Yuko Okano, Atsuro Takeshita, Mei Uemura, Taro Yasuma, Toshinari Suzuki, Ryuji Okamoto, D’Alessandro-Gabazza, Corina N., Gabazza, Esteban C., Yutaka Yano
Publikováno v:
Internal Medicine; 2024, Vol. 63 Issue 11, p1597-1602, 6p
Autor:
Yoko Ichikawa‐Kaji, Fujio Ishizawa, Rei Nishiyama, Hajime Tachikawa, Nozomi Uemura, Yuka Moriuchi, Yi‐Yang Hsiao, Takako Moriyasu, Toshinari Suzuki, Yoichiro Takahashi, Akiko Inomata
Publikováno v:
Drug Testing and Analysis. 15:345-360
Sexual enhancement products adulterated with phosphodiesterase 5 inhibitors (PDE-5i) pose a serious public health concern. Tadalafil and its analogues (Tds) are PDE-5i frequently detected as adulterants. In this study, a Td detector tube for the rapi
Autor:
Akihiro Yoshihara, Kota Nishihama, Chisa Inoue, Yuko Okano, Kazuhito Eguchi, Soichiro Tanaka, Kanako Maki, Valeria Fridman D'Alessandro, Atsuro Takeshita, Taro Yasuma, Mei Uemura, Toshinari Suzuki, Esteban C Gabazza, Yutaka Yano
Publikováno v:
World Journal of Clinical Cases. 10:5723-5731
Autor:
Miho Sakamoto, Toshinari Suzuki, Daisuke Teraoka, Kazue Tanaka, Yuki Saeki, Kiyoko Kishimoto, Machiko Nagashima, Jun’ichi Nakajima, Jin Suzuki, Akiko Inomata, Takako Moriyasu, Haruhiko Fukaya
Publikováno v:
Forensic Toxicology.
Autor:
Yoshio Nakagawa, Jin Suzuki, Toshinari Suzuki, Hideyo Takahashi, Kosho Makino, Yasushi Ono, Miho Sakamoto, Akiko Inomata
Publikováno v:
Journal of Applied Toxicology.
Autor:
Daisuke Teraoka, Miho Sakamoto, Kazue Tanaka, Yuki Saeki, Kiyoko Kishimoto, Machiko Nagashima, Toshinari Suzuki, Akiko Inomata, Takako Moriyasu
Publikováno v:
Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 142(8)
Topical Medicine No. 37-① is one of the in-pharmacy formulation that specifies a confirmation test (referred hereafter as the conventional method) to identify its ingredient diphenhydramine (DH) by colorimetric test. However, the conventional metho
Autor:
Yasushi Ono, Miho Sakamoto, Kosho Makino, Kuniaki Tayama, Yukie Tada, Yoshio Nakagawa, Jun’ichi Nakajima, Jin Suzuki, Toshinari Suzuki, Hideyo Takahashi, Akiko Inomata, Takako Moriyasu
Publikováno v:
Naunyn-Schmiedeberg's archives of pharmacology. 396(1)
New synthetic opioids continue to emerge in the illicit market, and among them, fentanyl analogues pose a serious threat to the public health with their abuse and trafficking. We investigated the toxicity of fentanyl analogues on the liver and kidney
Autor:
Toshinari Suzuki, Kanako Maki, Yutaka Yano, Taro Yasuma, Akihiro Uchida, Mei Uemura, Kota Nishihama, Kazuhito Eguchi, Esteban C. Gabazza, Soichiro Tanaka, Yuko Okano, Chisa Inoue, Corina N. D’Alessandro-Gabazza
Publikováno v:
World Journal of Clinical Cases
BACKGROUND Fulminant type 1 diabetes mellitus (FT1DM) is a subtype of type 1 diabetes mellitus characterized by an abrupt onset and a rapid and complete functional loss of islet β cells. It is a very rare disease generally associated with ketoacidos